rs1544515

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000719.7(CACNA1C):​c.617+17G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.252 in 1,503,642 control chromosomes in the GnomAD database, including 48,977 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 5594 hom., cov: 32)
Exomes 𝑓: 0.25 ( 43383 hom. )

Consequence

CACNA1C
NM_000719.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.741

Publications

11 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 12-2449132-G-A is Benign according to our data. Variant chr12-2449132-G-A is described in ClinVar as Benign. ClinVar VariationId is 93420.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.317 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.617+17G>A intron_variant Intron 4 of 46 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.617+17G>A intron_variant Intron 4 of 46 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.617+17G>A intron_variant Intron 4 of 46 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.617+17G>A intron_variant Intron 4 of 46 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.707+17G>A intron_variant Intron 4 of 49 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.617+17G>A intron_variant Intron 4 of 47 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.617+17G>A intron_variant Intron 4 of 46 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.707+17G>A intron_variant Intron 4 of 47 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.617+17G>A intron_variant Intron 4 of 48 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.617+17G>A intron_variant Intron 4 of 46 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.617+17G>A intron_variant Intron 4 of 47 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.617+17G>A intron_variant Intron 4 of 47 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.707+17G>A intron_variant Intron 4 of 46 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.707+17G>A intron_variant Intron 4 of 46 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.707+17G>A intron_variant Intron 4 of 46 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.707+17G>A intron_variant Intron 4 of 46 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.617+17G>A intron_variant Intron 4 of 47 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.617+17G>A intron_variant Intron 4 of 47 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.617+17G>A intron_variant Intron 4 of 47 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.617+17G>A intron_variant Intron 4 of 46 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.617+17G>A intron_variant Intron 4 of 46 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.617+17G>A intron_variant Intron 4 of 46 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.617+17G>A intron_variant Intron 4 of 46 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.617+17G>A intron_variant Intron 4 of 46 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.617+17G>A intron_variant Intron 4 of 45 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.617+17G>A intron_variant Intron 4 of 45 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.617+17G>A intron_variant Intron 4 of 45 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.617+17G>A intron_variant Intron 4 of 46 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.617+17G>A intron_variant Intron 4 of 46 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.617+17G>A intron_variant Intron 4 of 46 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.617+17G>A intron_variant Intron 4 of 46 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.617+17G>A intron_variant Intron 4 of 46 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.617+17G>A intron_variant Intron 4 of 46 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.617+17G>A intron_variant Intron 4 of 45 ENSP00000507309.1
CACNA1CENST00000682152.1 linkc.566+17G>A intron_variant Intron 3 of 5 ENSP00000506759.1
CACNA1CENST00000480911.6 linkn.617+17G>A intron_variant Intron 4 of 26 5 ENSP00000437936.2

Frequencies

GnomAD3 genomes
AF:
0.269
AC:
40815
AN:
151714
Hom.:
5583
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.322
Gnomad AMI
AF:
0.342
Gnomad AMR
AF:
0.228
Gnomad ASJ
AF:
0.323
Gnomad EAS
AF:
0.177
Gnomad SAS
AF:
0.304
Gnomad FIN
AF:
0.247
Gnomad MID
AF:
0.228
Gnomad NFE
AF:
0.251
Gnomad OTH
AF:
0.249
GnomAD2 exomes
AF:
0.251
AC:
34268
AN:
136684
AF XY:
0.254
show subpopulations
Gnomad AFR exome
AF:
0.330
Gnomad AMR exome
AF:
0.190
Gnomad ASJ exome
AF:
0.313
Gnomad EAS exome
AF:
0.179
Gnomad FIN exome
AF:
0.242
Gnomad NFE exome
AF:
0.249
Gnomad OTH exome
AF:
0.258
GnomAD4 exome
AF:
0.250
AC:
338422
AN:
1351810
Hom.:
43383
Cov.:
28
AF XY:
0.252
AC XY:
167424
AN XY:
663532
show subpopulations
African (AFR)
AF:
0.329
AC:
9774
AN:
29724
American (AMR)
AF:
0.187
AC:
5454
AN:
29156
Ashkenazi Jewish (ASJ)
AF:
0.313
AC:
7420
AN:
23744
East Asian (EAS)
AF:
0.205
AC:
7213
AN:
35242
South Asian (SAS)
AF:
0.293
AC:
20798
AN:
71040
European-Finnish (FIN)
AF:
0.243
AC:
11863
AN:
48868
Middle Eastern (MID)
AF:
0.254
AC:
1395
AN:
5492
European-Non Finnish (NFE)
AF:
0.247
AC:
260347
AN:
1052390
Other (OTH)
AF:
0.252
AC:
14158
AN:
56154
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
10292
20584
30877
41169
51461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9128
18256
27384
36512
45640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.269
AC:
40875
AN:
151832
Hom.:
5594
Cov.:
32
AF XY:
0.269
AC XY:
19936
AN XY:
74190
show subpopulations
African (AFR)
AF:
0.322
AC:
13299
AN:
41342
American (AMR)
AF:
0.228
AC:
3477
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.323
AC:
1121
AN:
3468
East Asian (EAS)
AF:
0.177
AC:
915
AN:
5172
South Asian (SAS)
AF:
0.305
AC:
1470
AN:
4812
European-Finnish (FIN)
AF:
0.247
AC:
2607
AN:
10550
Middle Eastern (MID)
AF:
0.235
AC:
69
AN:
294
European-Non Finnish (NFE)
AF:
0.251
AC:
17073
AN:
67920
Other (OTH)
AF:
0.254
AC:
533
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1523
3045
4568
6090
7613
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
428
856
1284
1712
2140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.259
Hom.:
4718
Bravo
AF:
0.270
Asia WGS
AF:
0.300
AC:
1041
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 23, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 10, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 21, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Timothy syndrome Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.16
DANN
Benign
0.51
PhyloP100
-0.74
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1544515; hg19: chr12-2558298; COSMIC: COSV59695531; API